New Drugs

Google is interested in investing in new ways to fight disease. Its investment portfolio includes a stake in Adimab, which uses a novel approach involving yeast cells to speed up the discovery of new antibodies. Another Google company,

iPierian, uses a technique called "cellular reprogramming" to create new drugs that attack diseases by modifying them.